C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Poly(2-methyl-2-oxazoline) (PMOXA) is an alternative promising polymer to poly(ethylene glycol) (PEG) for design and engineering of macrophage-evading nanoparticles (NPs). Although PMOXA-engineered NPs have shown comparable pharmacokinetics and in vivo performance to PEGylated stealth NPs in the murine model, its interaction with elements of the human innate immune system has not been studied. From a translational angle, we studied the interaction of fully characterized PMOXA-coated vinyltriethoxysilane-derived organically modified silica NPs (PMOXA-coated NPs) of approximately 100 nm in diameter with human complement system, blood leukocytes, and macrophages and compared their performance with PEGylated and uncoated NP counterparts. Through detailed immunological and proteomic profiling, we show that PMOXA-coated NPs extensively trigger complement activation in human sera exclusively through the classical pathway. Complement activation is initiated by the sensing molecule C1q, where C1q binds with high affinity ( K d = 11 ± 1 nM) to NP surfaces independent of immunoglobulin binding. C1q-mediated complement activation accelerates PMOXA opsonization with the third complement protein (C3) through the amplification loop of the alternative pathway. This promoted NP recognition by human blood leukocytes and monocyte-derived macrophages. The macrophage capture of PMOXA-coated NPs correlates with sera donor variability in complement activation and opsonization but not with other major corona proteins, including clusterin and a wide range of apolipoproteins. In contrast to these observations, PMOXA-coated NPs poorly activated the murine complement system and were marginally recognized by mouse macrophages. These studies provide important insights into compatibility of engineered NPs with elements of the human innate immune system for translational steps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
Pelegri-O’Day, E. M., Lin, E.-W., & Maynard, H. D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504390x · Cited by 622
Tailored poly(2-oxazoline) polymer brushes to control protein adsorption and cell adhesion
Zhang, N., Pompe, T., Amin, I., Luxenhofer, R., Werner, C., & Jordan, R. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200026 · Cited by 171
POxylation as an alternative stealth coating for biomedical applications
Bludau, H., Czapar, A. E., Pitek, A. S., Shukla, S., Jordan, R., & Steinmetz, N. F. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.10.041 · Cited by 112
Research works printed but not linked: 58
- 10.1146/annurev-pharmtox-010611-134623 · DOI · Paper page
- 10.1159/000339153 · DOI
- 10.1038/nnano.2012.237 · DOI · Paper page
- 10.2217/nnm.15.163 · DOI · Paper page
- 10.2165/00003088-200342050-00002 · DOI · Paper page
- 10.1016/j.bbadis.2004.02.005 · DOI
- 10.1016/j.molimm.2008.08.276 · DOI · Paper page
- 10.2147/IJN.S30943 · DOI · Paper page
- 10.1016/j.ijpharm.2012.07.049 · DOI
- 10.1016/j.ejps.2011.11.014 · DOI
- 10.1016/j.exphem.2016.11.001 · DOI
- 10.1016/j.biomaterials.2007.10.015 · DOI
- 10.1016/j.addr.2011.06.017 · DOI · Paper page
- 10.1016/j.jconrel.2014.08.009 · DOI
- 10.1038/nnano.2017.47 · DOI · Paper page
- 10.1007/s10856-013-5034-y · DOI · Paper page
- 10.1002/mabi.201600074 · DOI
- 10.1016/j.biomaterials.2010.02.057 · DOI · Paper page
- 10.1002/marc.201200422 · DOI · Paper page
- 10.1039/C5NR03178H · DOI · Paper page
- 10.1002/marc.201200453 · DOI · Paper page
- 10.1021/bc200049d · DOI · Paper page
- 10.1021/la702917z · DOI · Paper page
- 10.1021/js9504043 · DOI · Paper page
- 10.1002/mabi.201500021 · DOI · Paper page
- 10.1021/acs.langmuir.5b00537 · DOI
- 10.1021/bc00030a001 · DOI · Paper page
- 10.1186/s12989-014-0064-2 · DOI · Paper page
- 10.1039/b921735e · DOI
- 10.1016/j.jconrel.2015.11.021 · DOI · Paper page
- 10.1034/j.1600-065X.2001.1800103.x · DOI · Paper page
- 10.3389/fimmu.2015.00262 · DOI · Paper page
- 10.1007/s00005-013-0229-y · DOI
- 10.1078/0171-2985-00144 · doi:10.1078/0171-2985-00144
- 10.1016/S0161-5890(01)00004-9 · DOI
- 10.1074/jbc.M112.341339 · DOI · Paper page
- 10.4049/jimmunol.180.4.2329 · DOI · Paper page
- 10.1016/S0005-2736(99)00013-9 · DOI
- Kovacsovics T., 1985, J. Immunol., 135, 2695, 10.4049/jimmunol.135.4.2695 · DOI
- 10.1093/intimm/2.5.413 · DOI · Paper page
- Bhakdi S., 1988, Clin. Exp. Immunol., 74, 459
- Tschopp J., 1993, J. Immunol., 151, 2159, 10.4049/jimmunol.151.4.2159 · DOI · Paper page
- Hattori R., 1989, J. Biol. Chem., 264, 9053, 10.1016/S0021-9258(18)81901-9 · DOI · Paper page
- Jenne D. E., 1991, J. Biol. Chem., 266, 11030, 10.1016/S0021-9258(18)99123-4 · DOI · Paper page
- 10.1073/pnas.85.18.6949 · DOI · Paper page
- 10.1023/A:1016286310475 · DOI
- 10.1016/j.drudis.2017.11.006 · DOI
- 10.2217/nnm.14.22 · DOI
- 10.2217/nnm.11.30 · doi:10.2217/nnm.11.30
- 10.1385/0-89603-441-0:301 · doi:10.1385/0-89603-441-0:301
- 10.1039/C5NR05290D · DOI
- 10.4049/jimmunol.1200816 · DOI
- 10.1016/j.jim.2009.11.003 · doi:10.1016/j.jim.2009.11.003
- 10.1104/pp.15.00361 · DOI
- 10.1021/pr101065j · DOI · Paper page
- 10.1074/mcp.O111.014522 · DOI
- 10.1002/pmic.200400999 · DOI
- 10.1016/j.nano.2013.01.011 · DOI
Cited by
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Donahue, N. D., Acar, H., & Wilhelm, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.008 · Cited by 944
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Three decades of messenger RNA vaccine development
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100766 · Cited by 342
Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment
Yu, Z., Gao, L., Chen, K., Zhang, W., Zhang, Q., Li, Q., & Hu, K. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03489-z · Cited by 138
Metadata
- Authors
- Tavano, R., Gabrielli, L., Lubian, E., Fedeli, C., Visentin, S., Polverino De Laureto, P., Arrigoni, G., Geffner-Smith, A., Chen, F., Simberg, D., Morgese, G., Benetti, E. M., Wu, L., Moghimi, S. M., Mancin, F., & Papini, E.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-05-11
- Volume
- 12
- Issue
- 6
- Pages
- 5834-5847
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2800006797
- Cited by
- 141
- References
- 8
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Government of Guangdong Province (2015A050502002)
- Universit? degli Studi di Padova
- Guangzhou City (2016201604030050)
- Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- RiboBio Co, Ltd.
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. https://app.cochat.ai/papers/10.1021/acsnano.8b01806
- The paper
- Tavano, R., Gabrielli, L., Lubian, E., Fedeli, C., Visentin, S., Polverino De Laureto, P., Arrigoni, G., Geffner-Smith, A., Chen, F., Simberg, D., Morgese, G., Benetti, E. M., Wu, L., Moghimi, S. M., Mancin, F., & Papini, E. (2018). C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. ACS Nano. https://doi.org/10.1021/acsnano.8b01806
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.